Thrombolex, Inc.
PrivateLast Round
Series A
Mar 12, 2026
Total Funding Raised
$13.82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Thrombolex, Inc. is a medical device company that designs, develops, and distributes innovative endovascular catheters used in interventional procedures for patients who suffer from arterial and venous thromboembolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thrombolex, Inc. Comparables
Compare Thrombolex, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SonoVascular, Inc. | 92% | |
| Innova Vascular | 88% | |
| Inquis Medical | 88% | |
Thrombolex, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2026 | ||||
| Series B | Jun 4, 2024 | ||||
| VC Round | Aug 30, 2022 | ||||
| VC Round | Nov 29, 2021 | ||||
| Grant | Jul 5, 2020 | ||||
Series A | Feb 3, 2020 |
Thrombolex, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A |
| National Heart, Lung, and Blood Institute | Grant |
| Delaware Crossing Investor Group | VC Round, Series A |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 47% QoQ, from 17 to 25 employees.
- Jun 18, 2026
Monthly visitors increased 30% MoM, reaching 2.5K.
Thrombolex, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Thrombolex, Inc.'s valuation, stock price, and market status.